Milestone Scientific (MLSS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,714 | -6,981 | -8,773 | -6,876 | -7,389 |
| Depreciation Amortization | 135 | 151 | 144 | 147 | 96 |
| Accounts receivable | -163 | 356 | 250 | 137 | 630 |
| Accounts payable and accrued liabilities | 415 | -806 | 730 | 308 | -1,870 |
| Other Working Capital | -631 | -1,401 | -550 | 680 | -1,812 |
| Other Operating Activity | 2,038 | 3,354 | 2,167 | 1,570 | 3,360 |
| Operating Cash Flow | $-2,920 | $-5,326 | $-6,032 | $-4,034 | $-6,985 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,977 | -2,967 | N/A | N/A | N/A |
| PPE Investments | -10 | -5 | -9 | -15 | -21 |
| Investing Cash Flow | $2,966 | $-2,972 | $-9 | $-15 | $-21 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 276 |
| Debt Repayment | -10 | -9 | -9 | -9 | -8 |
| Common Stock Issued | 244 | 2,570 | N/A | 4,598 | 19,446 |
| Financing Cash Flow | $234 | $2,561 | $-9 | $4,589 | $19,714 |
| Beginning Cash Position | 2,978 | 8,715 | 14,764 | 14,224 | 1,516 |
| End Cash Position | 3,258 | 2,978 | 8,715 | 14,764 | 14,224 |
| Net Cash Flow | $280 | $-5,738 | $-6,049 | $540 | $12,708 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,920 | -5,326 | -6,032 | -4,034 | -6,985 |
| Capital Expenditure | -10 | -5 | -9 | -15 | -21 |
| Free Cash Flow | -2,930 | -5,331 | -6,041 | -4,049 | -7,006 |